Imatinib responsiveness in canine mast cell tumors carrying novel mutations of c-KIT Exon 11

Journal of Veterinary Medical Science

Volumn 76, Issue 4, 2014, Pages 545-548

  Nakano, Yuko ^a,b   Kobayashi, Tetsuya ^a   Oshima, Fukiko ^a   Fukazawa, Eri ^a   Yamagami, Tetsushi ^a   Shiraishi, Yozo ^a   Takanosu, Masamine ^a,c  

^a Japan Small Animal Cancer Center   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Nasunogahara Animal Clinic   (Japan)

Author keywords

c KIT; Canine; Imatinib mesylate; Mast cell tumor; Mutation

Indexed keywords

BENZAMIDE DERIVATIVE; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; STEM CELL FACTOR RECEPTOR;

ANIMAL; CASE REPORT; DNA SEQUENCE; DOG; DOG DISEASES; FEMALE; GENE DELETION; GENE STRUCTURE; GENETICS; LYMPH NODE METASTASIS; MALE; MASTOCYTOSIS; MISSENSE MUTATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; VETERINARY;

ANIMALS; BASE SEQUENCE; BENZAMIDES; DOG DISEASES; DOGS; FEMALE; GENE COMPONENTS; LYMPHATIC METASTASIS; MALE; MASTOCYTOSIS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PIPERAZINES; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; TREATMENT OUTCOME;

EID: 84899742944     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.13-0156     Document Type: Note

References (11)

1. Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., Fletcher, J. A., Silverman, S. G., Silberman, S. L., Capdeville, R., Kiese, B., Peng, B., Dimitrijevic, S., Druker, B. J., Corless, C., Fletcher, C. D. and Joensuu, H. 2002. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347: 472-480. [Medline] [CrossRef]
2. Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C. L. 2001. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344: 1031-1037. [Medline] [CrossRef]
3. Isotani, M., Ishida, N., Tominaga, M., Tamura, K., Yagihara, H., Ochi, S., Kato, R., Kobayashi, T., Fujita, M., Fujino, Y., Setoguchi, A., Ono, K., Washizu, T. and Bonkobara, M. 2008. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. J. Vet. Intern. Med. 22: 985-988. [Medline] [CrossRef]
4. Kobayashi, M., Kuroki, S., Ito, K., Yasuda, A., Sawada, H., Ono, K., Washizu, T. and Bonkobara, M. 2013. Imatinib-associated tumour response in a dog with a non-resectable gastrointestinal stromal tumour harbouring a c-kit exon 11 deletion mutation. Vet. J. 198: 271-274. [Medline] [CrossRef]
5. Kobayashi, M., Sugisaki, O., Ishii, N., Yamada, O., Ito, K., Kuroki, S., Sasaki, Y., Ono, K., Washizu, T. and Bonkobara, M. 2012. Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy. Vet. J. 193: 264-267. [Medline] [CrossRef]
6. Letard, S., Yang, Y., Hanssens, K., Palmerini, F., Leventhal, P. S., Guery, S., Moussy, A., Kinet, J. P., Hermine, O. and Dubreuil, P. 2008. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Mol. Cancer Res. 6: 1137-1145. [Medline] [CrossRef]
7. Lim, K. H., Huang, M. J., Chen, L. T., Wang, T. W., Liu, C. L., Chang, C. S., Liu, M. C., Hsieh, R. K. and Tzen, C. Y. 2008. Molecular analysis of secondary kinase mutations in imatinibresistant gastrointestinal stromal tumors. Med. Oncol. 25: 207-213. [Medline] [CrossRef]
8. Ma, Y., Longley, B. J., Wang, X., Blount, J. L., Langley, K. and Caughey, G. H. 1999. Clustering of activating mutations in c-KIT's juxtamembrane coding region in canine mast cell neoplasms. J. Invest. Dermatol. 112: 165-170. [Medline] [Cross-Ref]
9. Tan, C. B., Zhi, W., Shahzad, G. and Mustacchia, P. 2012. Gastrointestinal stromal tumors: a review of case reports, diagnosis, treatment, and future directions. ISRN Gastroenterol. 2012: 595968. [Medline] [CrossRef]
10. Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C. and Gwyther, S. G. 2000. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl. Cancer Inst. 92: 205-216. [Medline] [CrossRef]
11. Yamada, O., Kobayashi, M., Sugisaki, O., Ishii, N., Ito, K., Kuroki, S., Sasaki, Y., Isotani, M., Ono, K., Washizu, T. and Bonkobara, M. 2011. Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation. Vet. Immunol. Immunopathol. 142: 101-106. [Medline] [CrossRef]